Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
My friend and colleague, Dr. Ramiswamy Govindan, is one of the national leaders in lung cancer, and he was kind enough to participate in our NSCLC Patient Education Forum. There, he spoke in some general terms about what patients might expect from chemo/radiation for locally advanced lung cancer (which could include limited SCLC as well as stage III NSCLC), but he also used the occasion to talk about general guidelines about where we've come from and where we're going with cancer treatments. He also covered his impressions on diet, supplements, managing toxicities, and other practical aspects of receiving cancer treatment.
Here is the link to the audio and video versions of the podcast, as well as the figures and transcript.
[powerpress]
govindan lung ca past present future audio podcast
govindan-lung-ca-past-present-future-figures
govindan-lung-ca-past-present-future-transcript
I hope you find it interesting and helpful. We'll be posting the last few podcasts of presentations from the NSCLC Patient Education in the next few weeks, on the topic of advanced NSCLC.
Please feel free to offer comments and raise questions in our
discussion forums.
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.